Carl Elliott, M.D., Ph.D.
Professor, Center for Bioethics, University of Minnesota
Posted: 08/14/2013 1:29 pm
If stonewalling an investigation into human subjects research seems wrong than say something about it:
Sidenote observe Mike Howard’s comment:
“In order for this scheme to work, the FDA, which certifies all medicines as safe and effective before releasing them for public consumption, would have to play along. That proved to be no problem for Pharma and UMN, all you need to do is get the chair of the psychiatry department appointed to the state folmulary board and presto..magic..the antipsychotics become the most prescribed drugs in Minnesota.”
“Federal regulations and laws have not consistently targeted institutional conflicts of interest. The U.S. Public Health Service (PHS) regulations on conflict of interest, which were issued in 1995 and which are included in Appendix B, cover only individual conflicts of interest and relationships with industry. Institutional conflicts of interest were deliberately not addressed (NIH, 1995).”
from “Conflict of Interest in Medical Research, Education, and Practice.”